Dr. Yogita Rochlani, M.B.B.S

NPI: 1427498401
Total Payments
$6,620
2024 Payments
$690.25
Companies
20
Transactions
85
Medicare Patients
467
Medicare Billing
$145,346

Payment Breakdown by Category

Food & Beverage$4,538 (68.5%)
Travel$1,770 (26.7%)
Education$311.91 (4.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,538 74 68.5%
Travel and Lodging $1,770 8 26.7%
Education $311.91 3 4.7%

Top Paying Companies

Company Total Records Latest Year
Abbott Laboratories $3,466 38 $0 (2024)
Medtronic Vascular, Inc. $848.19 4 $0 (2019)
Ancora Heart, Inc. $504.00 1 $0 (2023)
AstraZeneca Pharmaceuticals LP $488.49 6 $0 (2024)
Actelion Pharmaceuticals US, Inc. $350.76 5 $0 (2024)
Janssen Pharmaceuticals, Inc $125.00 1 $0 (2017)
Bayer HealthCare Pharmaceuticals Inc. $123.05 1 $0 (2017)
Merck Sharp & Dohme LLC $114.61 6 $0 (2024)
Astellas Pharma US Inc $99.99 1 $0 (2019)
PFIZER INC. $82.47 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $690.25 26 Abbott Laboratories ($240.86)
2023 $895.43 11 Ancora Heart, Inc. ($504.00)
2022 $843.34 10 Abbott Laboratories ($773.56)
2021 $184.18 3 Abbott Laboratories ($151.69)
2020 $374.74 4 Abbott Laboratories ($374.74)
2019 $2,777 23 Abbott Laboratories ($1,645)
2018 $159.07 2 AstraZeneca Pharmaceuticals LP ($159.07)
2017 $696.15 6 Actelion Pharmaceuticals US, Inc. ($269.95)

All Payment Transactions

85 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/09/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $21.50 General
Category: Cardiology/Vascular Diseases
12/05/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $21.31 General
Category: CARDIOVASCULAR
12/04/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $28.00 General
Category: Cardiology
11/21/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.73 General
Category: Cardiology/Vascular Diseases
11/13/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.77 General
Category: CARDIOVASCULAR
11/06/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $23.80 General
Category: Heart Failure
10/28/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $21.41 General
Category: CARDIOVASCULAR
10/23/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $24.09 General
Category: Cardiology
10/16/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.30 General
Category: CARDIOVASCULAR
09/24/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $15.25 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/18/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.09 General
Category: CARDIOVASCULAR
09/17/2024 Alnylam Pharmaceuticals Inc. ONPATTRO (Drug) Food and Beverage In-kind items and services $28.00 General
Category: Genetic Disease
09/16/2024 Abbott Laboratories NAVITOR (Device) Food and Beverage In-kind items and services $24.96 General
Category: Vascular
08/21/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $19.60 General
Category: CARDIOVASCULAR
08/06/2024 Abbott Laboratories THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) Food and Beverage In-kind items and services $12.12 General
Category: Heart Failure
06/21/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $16.62 General
Category: Cardiovascular
05/17/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $17.02 General
Category: Cardiovascular
04/12/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $17.12 General
Category: Cardiovascular
04/03/2024 Takeda Pharmaceuticals U.S.A., Inc. LIVTENCITY (Drug) Food and Beverage In-kind items and services $23.16 General
Category: IMMUNOLOGY
03/27/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $20.82 General
03/20/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $15.54 General
Category: CARDIOVASCULAR
02/28/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $20.57 General
Category: Cardiovascular
02/28/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $15.25 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
02/06/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $31.26 General
Category: Cardiology
01/31/2024 Takeda Pharmaceuticals U.S.A., Inc. LIVTENCITY (Drug) Food and Beverage In-kind items and services $16.98 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 143 332 $289,780 $40,691
2022 6 128 259 $244,319 $38,139
2021 5 117 276 $249,470 $40,298
2020 3 79 202 $152,845 $26,218
Total Patients
467
Total Services
1,069
Medicare Billing
$145,346
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 35 106 $140,450 $21,040 15.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 39 129 $69,015 $9,483 13.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 25 52 $26,260 $4,457 17.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 31 32 $36,371 $3,665 10.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $17,684 $2,046 11.6%
99291 Critical care, first 30-74 minutes Facility 2022 47 120 $159,000 $25,169 15.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 19 45 $25,875 $4,154 16.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 12 20 $13,600 $2,540 18.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 17 29 $14,645 $2,509 17.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 21 33 $17,655 $2,222 12.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 12 12 $13,544 $1,545 11.4%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 50 138 $172,210 $28,443 16.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 20 56 $30,440 $5,332 17.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 13 30 $14,910 $2,744 18.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 23 41 $22,375 $2,703 12.1%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 11 11 $9,535 $1,076 11.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 30 82 $93,070 $17,069 18.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 37 85 $42,450 $5,727 13.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 12 35 $17,325 $3,422 19.8%

About Dr. Yogita Rochlani, M.B.B.S

Dr. Yogita Rochlani, M.B.B.S is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1427498401.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yogita Rochlani, M.B.B.S has received a total of $6,620 in payments from pharmaceutical and medical device companies, with $690.25 received in 2024. These payments were reported across 85 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,538).

As a Medicare-enrolled provider, Rochlani has provided services to 467 Medicare beneficiaries, totaling 1,069 services with total Medicare billing of $145,346. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.

Practice Information

Products in Payments

  • HeartMate PHP (Device) $1,479
  • THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,270
  • AccuCinch (Device) $504.00
  • BRILINTA (Drug) $184.99
  • Mitra Clip system (Device) $183.28
  • Ensite Cardiac Mapping System (Device) $151.93
  • MitraClip System (Device) $151.69
  • Allure CRT Pacemaker (Device) $134.27
  • XARELTO (Drug) $125.00
  • Adempas (Drug) $123.05
  • OPSUMIT MACITENTAN (Drug) $120.91
  • VERQUVO (Drug) $114.61
  • ELIQUIS (Drug) $81.26
  • OPSUMIT (Drug) $80.81
  • HeartMate 3 Left Ventricular Dev (Device) $63.30
  • LifeVest (Device) $62.00
  • Barostim Neo System (Device) $60.37
  • VYNDAQEL (Drug) $51.97
  • LIVTENCITY (Drug) $40.14
  • LEQVIO (Drug) $39.23

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx